Furthermore, the ERK1/2 signaling pathway has also been reported as a promoting factor of tumor ECM degradation and angiogenesis, contributing to the proliferation, invasion, and metastasis of malignant tumors (48). This evidence concerns the gene MAPK3 and cancer.